glp-1 news today october 2025 🟣 FDA Approves Wegovy HD (semaglutide 7.2 mg) — the highest-dose RA yet for chronic weight management in adults with obesity or overweight + ≥1 weight-related condition. 🟣 Lightning-fast approval in LY3298176 Intra EAA Flavour:Fruit Splash Semaglutide Weight Loss Dosage:

glp-1 news today october 2025 🟣 FDA Approves Wegovy HD (semaglutide 7.2 mg) — the highest-dose RA yet for chronic weight management in adults with obesity or overweight + ≥1 weight-related condition. 🟣 Lightning-fast approval in LY3298176 Intra EAA Flavour:Fruit Splash Semaglutide Weight Loss Dosage:

Semaglutide Weight Loss Dosage: Finding The Right Amount [DKsMr5RviU4]

In our analysis, we will focus on the particularly strong opportunity for tech-enabled companion products that help GLP-1 patients make food and lifestyle choices with ease

LY3298176

Intra EAA Flavour:Fruit Splash

Yet in April 2024, the smaller LIXIPARK trial had shown the opposite, with lixisenatide slowing motor decline in early Parkinson’s disease over 12 months [3]